Ozaki R - Search Results

1

A simple risk score to identify Southern Chinese at high risk for diabetes.

Ko G, So W, Tong P, Ma R, Kong A, Ozaki R, Chow C, Cockram C, Chan J. Ko G, et al. Among authors: ozaki r. Diabet Med. 2010 Jun;27(6):644-9. doi: 10.1111/j.1464-5491.2010.02993.x. Diabet Med. 2010. PMID: 20546281

2

Non-linear relationship between birthweight and cardiometabolic risk factors in Chinese adolescents and adults.

Tam CH, Wang Y, Luan J, Lee HM, Luk AO, Tutino GE, Tong PC, Ko GT, Ozaki R, Tam WH, Kong AP, So WY, Chan JC, Ma RC. Tam CH, et al. Among authors: ozaki r. Diabet Med. 2015 Feb;32(2):220-5. doi: 10.1111/dme.12630. Epub 2014 Nov 30. Diabet Med. 2015. PMID: 25388749

3

Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) Registry.

Luk AO, Li X, Zhang Y, Guo X, Jia W, Li W, Weng J, Yang W, Chan WB, Ozaki R, Tsang CC, Mukhopadhyay M, Ojha AK, Hong EG, Yoon KH, Sobrepena L, Toledo RM, Duran M, Sheu W, Q Do T, Nguyen TK, Ma RC, Kong AP, Chow CC, Tong PC, So WY, Chan JC; JADE Study Group. Luk AO, et al. Among authors: ozaki r. Diabet Med. 2016 Sep;33(9):1230-9. doi: 10.1111/dme.13014. Epub 2015 Dec 6. Diabet Med. 2016. PMID: 26511783

4

A multicentre demonstration project to evaluate the effectiveness and acceptability of the web-based Joint Asia Diabetes Evaluation (JADE) programme with or without nurse support in Chinese patients with Type 2 diabetes.

Tutino GE, Yang WY, Li X, Li WH, Zhang YY, Guo XH, Luk AO, Yeung RO, Yin JM, Ozaki R, So WY, Ma RC, Ji LN, Kong AP, Weng JP, Ko GT, Jia WP, Chan JC; China JADE Study Group. Tutino GE, et al. Among authors: ozaki r. Diabet Med. 2017 Mar;34(3):440-450. doi: 10.1111/dme.13164. Epub 2016 Jul 11. Diabet Med. 2017. PMID: 27278933 Free PMC article. Clinical Trial.

5

High risk of conversion to diabetes in first-degree relatives of individuals with young-onset type 2 diabetes: a 12-year follow-up analysis.

Zhang Y, Luk AOY, Chow E, Ko GTC, Chan MHM, Ng M, Kong APS, Ma RCW, Ozaki R, So WY, Chow CC, Chan JCN. Zhang Y, et al. Among authors: ozaki r. Diabet Med. 2017 Dec;34(12):1701-1709. doi: 10.1111/dme.13516. Epub 2017 Oct 14. Diabet Med. 2017. PMID: 28945282

6

Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus.

Tong PC, Kong AP, So WY, Yang X, Ng MC, Ho CS, Ma RC, Ozaki R, Ng V, Chow CC, Lam CW, Chan JC, Cockram CS. Tong PC, et al. Among authors: ozaki r. Diabet Med. 2007 Jul;24(7):741-6. doi: 10.1111/j.1464-5491.2007.02145.x. Epub 2007 Apr 2. Diabet Med. 2007. PMID: 17403120

7

The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.

Luk AO, Ma RC, So WY, Yang XL, Kong AP, Ozaki R, Ko GT, Chow CC, Cockram CS, Chan JC, Tong PC. Luk AO, et al. Among authors: ozaki r. Diabet Med. 2008 Dec;25(12):1419-25. doi: 10.1111/j.1464-5491.2008.02602.x. Diabet Med. 2008. PMID: 19046240

8

Hypoadiponectinaemia enhances waist circumference as a predictor of glucose intolerance and clustering of risk factors in Chinese men.

Ko GT, So WY, Tong P, Ma RC, Kong AP, Ozaki R, Yang X, Ho CS, Lam CW, Chan JC. Ko GT, et al. Among authors: ozaki r. Diabetes Metab. 2010 Jun;36(3):192-7. doi: 10.1016/j.diabet.2009.11.007. Epub 2010 Mar 4. Diabetes Metab. 2010. PMID: 20202879

9

Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients With Type 2 Diabetes.

Jiang G, Luk AO, Tam CHT, Ozaki R, Lim CKP, Chow EYK, Lau ES, Kong APS, Fan B; Hong Kong Diabetes Register TRS Study Group; Lee KF, Siu SC, Hiu G, Tsang CC, Lau KP, Leung JY, Tsang MW, Kam G, Lau IT, Li JK, Yeung VT, Lau E, Lo S, Fung S, Cheng YL, Chow CC; Hong Kong Diabetes Biobank Study Group; Tang NLS, Huang Y, Lan HY, Oram RA, Szeto CC, So WY, Chan JCN, Ma RCW. Jiang G, et al. Among authors: ozaki r. Diabetes. 2022 Mar 1;71(3):520-529. doi: 10.2337/db21-0694. Diabetes. 2022. PMID: 35043149 Free PMC article.

10

A randomized-controlled trial to investigate the effects of rivoglitazone, a novel PPAR gamma agonist on glucose-lipid control in type 2 diabetes.

Kong AP, Yamasaki A, Ozaki R, Saito H, Asami T, Ohwada S, Ko GT, Wong CK, Leung GT, Lee KF, Yeung CY, Chan JC. Kong AP, et al. Among authors: ozaki r. Diabetes Obes Metab. 2011 Sep;13(9):806-13. doi: 10.1111/j.1463-1326.2011.01411.x. Diabetes Obes Metab. 2011. PMID: 21492364 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters